Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2023-01-09–present
Nat Calloway
Board Member
Lifecore Biomedical, Inc. \De\ (LFCR)Equibles does not estimate personal net worth.
About Nat Calloway
Nat Calloway is recorded as Board Member at Lifecore Biomedical, Inc. \De\ (LFCR) since January 9, 2023. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed January 10, 2023 that Nat Calloway was appointed Class 2 director, effective January 9, 2023. Lifecore Biomedical, Inc. \De\ is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Lifecore Biomedical, Inc. \De\ includes Paul Josephs (CEO and Board Member), Craig A. Barbarosh (Chairman), Katrina L. Houde (Chairman and Board Member) and 7 others.
“Pursuant to the Series A Director Right and effective as of the Closing Date, the Board appointed Nat Calloway, 40, to the Board as a new Class 2 director, and Christopher Kiper, 52, as a Class 1 Director.”
Affiliation history
-
Current
2023-01-09–present
Company network
Leadership on record at Lifecore Biomedical, Inc. \De\
- Paul Josephs CEO, Board Member
- Craig A. Barbarosh Chairman
- Katrina L. Houde Chairman, Board Member
- Brian McLaughlin CFO
- John Morberg CFO
- Ryan D. Lake CFO
- Christopher S. Kiper Board Member
- Humberto Antunes Board Member
- Humberto C. Antunes Board Member
- James G. Hall Board Member